• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags pharmaceutical safety

pharmaceutical safety News

Business

Laurus Labs Faces USFDA Scrutiny: A Closer Look at the Recent Form 483 Observation

Christopher Adams 23 Jan, 2025

Laurus Labs' US subsidiary, Laurus Generics Inc, received a Form 483 with one observation from the USFDA following a detailed inspection. The company is committed to addressing the...

Popular News

  • Economy

    President Trump Signals Flexibility on August 1 Tariff Deadline Amid Ongoing Negotiations

    08 Jul, 2025
  • Market

    US Crude Oil Inventories Drop by 4.7M Barrels, API Data Reveals

    18 Dec, 2024
  • Property

    Hong Kong's Pop Diva Karen Mok Invests in a $10.8M Luxury Apartment Amidst Market Downturn

    07 Jul, 2025
  • Economy

    Trump's Strategic Move: Delayed Reciprocal Tariffs Set to Reshape US Trade Policy

    14 Feb, 2025
  • Business

    Karnataka Proposes Rs 200 Movie Ticket Price Cap: A Boon for Moviegoers, A Bane for Multiplex Giants Like PVR-Inox

    16 Jul, 2025
  • Economy

    Eurozone Investor Confidence Plummets in December: What's Behind the Decline?

    10 Dec, 2024
  • Business

    Indian Exporters Eye UK Market to Counterbalance US Trade Losses Amid New Agreement

    07 May, 2025
  • Market

    US Stock Markets Rally as Federal Reserve Holds Interest Rates Steady

    31 Jan, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.